Latest News about MRK
Recent news which mentions MRK
Is Moderna Stock a Buy After Plunging More Than 35%?
October 13, 2021
From Motley Fool
3 COVID Stocks That Can Turn $1,000 Into $10,000
October 12, 2021
From Motley Fool
Novavax Will Be Volatile Until the Company Delivers Answers
October 12, 2021
From InvestorPlace
‘I’m getting compassion fatigue’: My parents said they’d rather quit their jobs and lose everything than get the COVID-19 vaccine
October 12, 2021
From MarketWatch
Winners and Losers of Rising Energy Prices
October 12, 2021
From Benzinga
MINDCURE's "Desire Project" uses MDMA to Treat Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
October 12, 2021
From Benzinga
Novavax Stock Will Find Its Bottom, But Probably not Soon
October 12, 2021
From InvestorPlace
Molnupiravir? Not So Fast. What About Tollovir? — Here's Why You Should Know What That Means
October 12, 2021
From Benzinga
What's Hot in the Stock Market?
October 11, 2021
From Motley Fool
Novavax Stock Got Merck-ed, but Don’t Dump Your Shares Now
October 11, 2021
From InvestorPlace
Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment
October 11, 2021
From MarketWatch
Cassava Sciences: Fine Trading Stock, Terrible Investment
October 11, 2021
From InvestorPlace
Merck, Ridgeback File For Emergency Use Nod For COVID-19 Antiviral
October 11, 2021
Tickers
MRK
From Benzinga
From Motley Fool
Why the new SEC sheriff could be trouble for companies like Tesla
October 11, 2021
From MarketWatch
Vaxart May Be a COVID Vaccine Game Changer -- but Is It Too Late?
October 10, 2021
From Motley Fool
3 Top Warren Buffett Stocks to Buy in October
October 10, 2021
From Motley Fool
Why Pfizer Will Profit From Merck's Rival Pneumococcal Vaccine
October 09, 2021
From Motley Fool
3 Reasons to Buy Merck Stock Right Now
October 09, 2021
From Motley Fool
Regeneron Could Have a Big Catalyst Coming in 2022
October 09, 2021
From Motley Fool
Better Bet on COVID Pills: Merck or Pfizer?
October 09, 2021
From Motley Fool
Indian Study Shows Merck's COVID-19 Antiviral Candidate Less Effective Against Moderate Infection: Reuters
October 08, 2021
From Benzinga
7 Defensive Stocks to Buy and Forget About In Times of Volatility
October 08, 2021
From InvestorPlace
Moderna Stock Looks Fully Valued Here, But It Has a Great Future
October 08, 2021
Tags
NASDAQ:MRNA,NYSE:MRK,NYSE:AZN,NASDAQ:BNTX,NYSE:PFE,NASDAQ:GILD,NYSE:GSK,NYSE:SNE
Market News
GILD
From InvestorPlace
From Motley Fool
Is an Acquisition of Acceleron a Smart Move for Merck?
October 08, 2021
From Motley Fool
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.